GB1523241A

GB1523241A – 2-(carboxymethoxy)-chalcones
– Google Patents

GB1523241A – 2-(carboxymethoxy)-chalcones
– Google Patents
2-(carboxymethoxy)-chalcones

Info

Publication number
GB1523241A

GB1523241A
GB3220/77A
GB322077A
GB1523241A
GB 1523241 A
GB1523241 A
GB 1523241A
GB 3220/77 A
GB3220/77 A
GB 3220/77A
GB 322077 A
GB322077 A
GB 322077A
GB 1523241 A
GB1523241 A
GB 1523241A
Authority
GB
United Kingdom
Prior art keywords
chalcones
carboxymethoxy
Prior art date
1976-02-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Application number
GB3220/77A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Taisho Pharmaceutical Co Ltd

Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1976-02-13
Filing date
1977-01-26
Publication date
1978-08-31

1977-01-26
Application filed by Taisho Pharmaceutical Co Ltd
filed
Critical
Taisho Pharmaceutical Co Ltd

1978-08-31
Publication of GB1523241A
publication
Critical
patent/GB1523241A/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS

C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups

C07C59/40—Unsaturated compounds

C07C59/76—Unsaturated compounds containing keto groups

C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS

C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds

C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups

C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton

C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms

C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form

C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups

GB3220/77A
1976-02-13
1977-01-26
2-(carboxymethoxy)-chalcones

Expired

GB1523241A
(en)

Applications Claiming Priority (1)

Application Number
Priority Date
Filing Date
Title

JP1457876A

JPS5297950A
(en)

1976-02-13
1976-02-13
Chalconeether derivatives

Publications (1)

Publication Number
Publication Date

GB1523241A
true

GB1523241A
(en)

1978-08-31

Family
ID=11865033
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

GB3220/77A
Expired

GB1523241A
(en)

1976-02-13
1977-01-26
2-(carboxymethoxy)-chalcones

Country Status (12)

Country
Link

US
(1)

US4085135A
(en)

JP
(1)

JPS5297950A
(en)

AR
(1)

AR209544A1
(en)

CA
(1)

CA1084064A
(en)

CH
(1)

CH605537A5
(en)

DE
(1)

DE2705603C2
(en)

ES
(1)

ES455620A1
(en)

FR
(1)

FR2340924A1
(en)

GB
(1)

GB1523241A
(en)

HU
(1)

HU173019B
(en)

PT
(1)

PT66118B
(en)

YU
(1)

YU39378B
(en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4190671A
(en)

*

1977-03-17
1980-02-26
Biorex Laboratories Limited
Chalcone derivatives

JPS5552597U
(en)

*

1978-09-30
1980-04-08

JPS62207212A
(en)

*

1986-03-08
1987-09-11
Nippon Haipotsukusu:Kk
Antiallergic agent

US5089654A
(en)

*

1989-08-08
1992-02-18
Taisho Pharmaceutical Co., Ltd.
Chalcone derivatives

US6103765A
(en)

1997-07-09
2000-08-15
Androsolutions, Inc.
Methods for treating male erectile dysfunction

EP1005336A4
(en)

1997-07-09
2001-01-17
Androsolutions Inc
Improved methods and compositions for treating male erectile dysfunction

KR20030031500A
(en)

*

2000-06-20
2003-04-21
아테로제닉스, 인코포레이티드
1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders

BR0115474A
(en)

2000-11-17
2006-01-31
Idenix Cayman Ltd

Composition and method for inhibiting hiv transmission using topically applied 6-benzyl-4-oxopyrimidines

EP1465854A4
(en)

*

2001-12-19
2005-06-08
Atherogenics Inc
Chalcone derivatives and their use to treat diseases

US20040181075A1
(en)

*

2002-12-19
2004-09-16
Weingarten M. David
Process of making chalcone derivatives

WO2004108094A2
(en)

*

2003-06-06
2004-12-16
Atherogenics, Inc.
Sulfonamide-substituted chalcone derivatives and their use to treat diseases

US20060063828A1
(en)

*

2004-06-28
2006-03-23
Weingarten M D
1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof

GB2471619B
(en)

*

2008-03-31
2012-10-31
Council Scient Ind Res
Method for the simultaneous preparation of 3-acetoxy-17-acetamdo-16-formyl-androst-5,16-diene and 3-acetoxy-2′-chloro-5-androsteno[17,6-B]pyridine

CN101781195B
(en)

*

2009-12-10
2013-03-13
天津药物研究院
Crystal form VII of sofalcone and preparation method and application thereof

CN101735039B
(en)

*

2009-12-10
2013-06-26
天津药物研究院
Crystal form II of sofalcone and preparation method and application thereof

CN101781194B
(en)

*

2009-12-10
2013-05-15
天津药物研究院
Crystal form V of sofalcone and preparation method and application thereof

CN101817741B
(en)

*

2009-12-10
2013-10-16
天津药物研究院
Crystal form IX of sofalcone, preparation method and use thereof

CN101781192B
(en)

*

2009-12-10
2013-05-15
天津药物研究院
Crystal form VI of sofalcone and preparation method and application thereof

CN101792385B
(en)

*

2009-12-10
2013-05-15
天津药物研究院
Sofalcone crystals VIII, preparation method thereof and use thereof

CN101781193B
(en)

*

2009-12-10
2013-05-15
天津药物研究院
Crystal form IV of sofalcone and preparation method and application thereof

CN101735038B
(en)

*

2009-12-10
2013-06-26
天津药物研究院
Crystal form I of sofalcone and preparation method and application thereof

CN101817742B
(en)

*

2009-12-10
2013-10-16
天津药物研究院
Crystal form X of sofalcone, preparation method and use thereof

CN101735040B
(en)

*

2009-12-10
2013-05-15
天津药物研究院
Crystal form III of sofalcone and preparation method and application thereof

CN115368265B
(en)

*

2022-10-24
2023-03-28
中国中医科学院中药研究所
Sofalcone small molecule active probe and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US3255241A
(en)

*

1961-01-19
1966-06-07
Merck & Co Inc
(2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids

CH593224A5
(en)

*

1973-10-30
1977-11-30
Taisho Pharma Co Ltd

1976

1976-02-13
JP
JP1457876A
patent/JPS5297950A/en
active
Granted

1977

1977-01-10
AR
AR266135A
patent/AR209544A1/en
active

1977-01-14
YU
YU89/77A
patent/YU39378B/en
unknown

1977-01-26
FR
FR7702191A
patent/FR2340924A1/en
active
Granted

1977-01-26
GB
GB3220/77A
patent/GB1523241A/en
not_active
Expired

1977-01-27
PT
PT66118A
patent/PT66118B/en
unknown

1977-02-03
ES
ES455620A
patent/ES455620A1/en
not_active
Expired

1977-02-04
CA
CA271,121A
patent/CA1084064A/en
not_active
Expired

1977-02-09
CH
CH155477A
patent/CH605537A5/xx
not_active
IP Right Cessation

1977-02-10
DE
DE2705603A
patent/DE2705603C2/en
not_active
Expired

1977-02-10
HU
HU77TA00001427A
patent/HU173019B/en
not_active
IP Right Cessation

1977-02-11
US
US05/767,974
patent/US4085135A/en
not_active
Expired – Lifetime

Also Published As

Publication number
Publication date

YU39378B
(en)

1984-12-31

DE2705603A1
(en)

1977-08-18

CA1084064A
(en)

1980-08-19

JPS5645896B2
(en)

1981-10-29

DE2705603C2
(en)

1986-07-24

JPS5297950A
(en)

1977-08-17

AR209544A1
(en)

1977-04-29

US4085135A
(en)

1978-04-18

YU8977A
(en)

1982-06-30

PT66118A
(en)

1977-02-01

HU173019B
(en)

1979-01-28

FR2340924A1
(en)

1977-09-09

FR2340924B1
(en)

1979-03-23

CH605537A5
(en)

1978-09-29

PT66118B
(en)

1978-06-28

AU2131077A
(en)

1978-01-26

ES455620A1
(en)

1978-01-01

Similar Documents

Publication
Publication Date
Title

AU517514B2
(en)

1981-08-06

3-de-0-methylfortimicins

AU2542577A
(en)

1978-11-30

4-amino-4-arylcyclohexanones

AU2384277A
(en)

1978-10-05

Triazolo-pyrimidines

GB1523241A
(en)

1978-08-31

2-(carboxymethoxy)-chalcones

CS164777A2
(en)

1987-01-15

Zpusob ziskavani krystalickeho xylitolu farmaceuricke jakosti

GB1522457A
(en)

1978-08-23

Benzocycloheptafurans

CS474677A2
(en)

1987-06-11

Obrazovy zesilovac

AU3191677A
(en)

1979-06-28

Cyclopentan-1-amine

AU2726877A
(en)

1979-02-01

Benzofuranyl-benzimidazoles

AU507260B2
(en)

1980-02-07

N-2-imidazolidinylidene-benzeneamine

AU2451277A
(en)

1978-10-26

Isothiazolopyridines

AU2714177A
(en)

1979-01-25

Phenoxy-hydroxypropylamines

AU2168677A
(en)

1978-08-03

2-(3-m-hydroxy-phenyl-1-substituted-3-pyrrolidinyl)- ethanol

AU1309176A
(en)

1977-10-20

Fire-barriers

BG23251A1
(en)

1979-12-12

Stabilograph

BG28564A4
(en)

1980-05-15

– 3- cyclohexen- 1- ona

GB1520699A
(en)

1978-08-09

Benzoxazolenes

AU508067B2
(en)

1980-03-06

Electroradiography

AU2493077A
(en)

1978-11-09

2-amino-substituted-isothioureido bewzenes

CY1158A
(en)

1983-01-28

Arylmalonamido-1-oxadethiacephalosporins

AU2893177A
(en)

1979-03-29

Perhydroindolinols

BG31468A3
(en)

1982-01-15

Mikrobicidnoe sredstvo

IE45688L
(en)

1978-03-30

2-(dimethylcarbamoylimino)-benzthiazolin-3-carboxylic acid¹esters

AU3192177A
(en)

1979-06-28

2-methoxybenzamides

AU2710877A
(en)

1979-01-25

Benzodioxepins

Legal Events

Date
Code
Title
Description

1978-12-29
PS
Patent sealed [section 19, patents act 1949]

1993-09-22
PCNP
Patent ceased through non-payment of renewal fee

Effective date:
19930126

Download PDF in English

None